Abstract
Keywords
Adalimumab (273)ADHD stimulants (extended release) (255)Angiotensin receptor blockers (247)Antidepressants (264)Belatacept (269)Botulinum toxin A (265)Chikungunya vaccine (249)Clarithromycin (247)COVID vaccine (251)Dextroamphetamine (270)Dolutegravir (272)Durvalumab (275)Gadolinium-based contrast agents (274)Gonadotropin-releasing hormone analog (266)Histamine-2 receptor antagonists (259)Imiglucerase (271)Immune checkpoint inhibitors (261,262)Infliximab (276)Ipilimumab (257)Lamotrigine (248)Medications (253,254,258)Nivolumab (257)PD-1 inhibitors (260)PDE type-5 inhibitors (267)Pembrolizumab (263)Proton pump inhibitors (259)Rituximab (250)Scopolamine (Transdermal) (256)SSRIs (268)Tamoxifen (252)Tremelimumab (275)Viloxazine (270)Vortioxetine (276)
Get full access to this article
View all access options for this article.